Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0594 in Alcohol Dependence
NCT00835718Phase 2Terminated
- Sponsor
- Vyne Therapeutics
- Start
- Feb 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of serlopitant in alcohol dependence, sponsored by Vyne Therapeutics. Started Feb 2009; status: terminated.
02
Drugs
serlopitant
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00835718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835718.